Evogene (EVGN) Operating Leases (2018 - 2026)

Evogene has disclosed Operating Leases across 9 years of filings, most recently posting $668000.0 for Q2 2026.

• In Q2 2026, Operating Leases fell 1.76% year-over-year to $668000.0; the TTM figure through Jun 2026 stood at $668000.0 (down 1.76% YoY), while the FY2025 annual figure was $716000.0, up 21.56% from the prior year.
• Operating Leases came in at $668000.0 for Q2 2026 at Evogene, up from $654000.0 in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $1.8 million in Q4 2022 to a low of $417000.0 in Q3 2024.
• Average Operating Leases over 5 years is $808444.4, with a median of $715500.0 recorded in 2024.
• Year-over-year, Operating Leases sank 51.17% in 2024 and soared 61.87% in 2025.
• Over 5 years, Operating Leases stood at $1.8 million in 2022, then plunged by 37.33% to $1.1 million in 2023, then slumped by 48.24% to $589000.0 in 2024, then increased by 21.56% to $716000.0 in 2025, then decreased by 6.7% to $668000.0 in 2026.
• Per Business Quant data, the three most recent Operating Leases figures were $668000.0 in Q2 2026, $654000.0 in Q1 2026, and $716000.0 in Q4 2025.